Search

Your search keyword '"Jokic, M."' showing total 154 results
Start Over Author "Jokic, M."
154 results on '"Jokic, M."'

18. Anaphylaxis admissions in pediatric intensive care units: Follow‐up and risk of recurrence.

Author

Pouessel, Guillaume, Cerbelle, Valentine, Lejeune, Stephanie, Leteurtre, Stephane, Ramdane, Nassima, Deschildre, Antoine, Tourneux, P, Boussicault, G, Thiriez, G, Brissaud, O, Garenne, A, Jokic, M, Petit, I, Semama, D, Bergounioux, J, Debillon, T, Wroblewski, I, Dorkenoo Morgan, RA, Mallet, E, and Javouhey, E

Subjects
HOSPITAL admission & discharge, INTENSIVE care units, ANAPHYLAXIS, FOLLOW-up studies (Medicine), FOOD allergy, CHILD nutrition
Abstract

Background: Data about the risk of anaphylaxis recurrence in children are lacking. We assessed anaphylaxis recurrence and medical follow‐up in a cohort of children previously hospitalized in a French pediatric intensive care unit (PICU) for anaphylaxis. Methods: We conducted a telephone survey of 166 children (≤18 years) hospitalized from 2003 to 2013. Results: In all, 106 (64%) completed the survey (boys, 59%; mean age [SD]: 15.3 years [5.5]). The main index triggers were drugs (45%) and foods (37%). The mean duration follow‐up was of 7.7 years (SD: 2.4). Thirty‐eight (36%) children experienced 399 new allergic reactions during a follow‐up period of 282 patient‐years (incidence rate: 1.4/100 patients/y; 95% CI: 0.64‐2.04). Twelve children experienced 19 anaphylaxis reactions including five requiring PICU admission (anaphylaxis recurrence rate: 0.20/100 patients/y; 95% CI non‐calculable). Food was the trigger for 79% of recurrent reactions and drugs for 8%. The food trigger was previously known in 83%, the same as the index trigger in 69%. Overall, 1.5% of the recurrent reactions were treated with adrenaline injection and 8% an emergency hospital admission. Patients with recurrence had more likely a history of food allergy (P < 10−4), asthma (P < 0.005), atopic dermatitis (P < 0.05) than those without. 31% of the 50 children with food allergy did not see an allergist, 23% had no adrenaline auto‐injector, and 26% lacked a school individual healthcare plan. Conclusions: Following a PICU admission for anaphylaxis, recurrence is high in children with food allergy compared with drug allergy. Allergic comorbidities increase the risk. Medical follow‐up has to be improved for these at‐risk children. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

21. Renal

Author

Picca S., Bartuli A., Dionisi-Vici C., Dello Strologo L., Villani A., Bianchi R., Salvatori G., Rizzoni G., O’Sabetta G., Jouvet, P., Poggi, F., Rabier, D., Saudubray, J. M., Man, N., Nguyen, V. B., Jokic, M., Lecacheux, C., Baines, P. B., Smith, L., and Petros, A.

Published
1996
Full Text
View/download PDF

26. [Fulminant influenza type A associated myocarditis: a fatal case in an 8 year old child]

Author

Letouze N, Jokic M, Maragnes P, Rouleau V, Flais F, Astrid VABRET, and Freymuth F

Subjects
Myocarditis, Extracorporeal Membrane Oxygenation, Fatal Outcome, Influenza A virus, Influenza, Human, Humans, Female, Child
Abstract

Fulminant Influenza type A-associated myocarditis are very rare in children. The clinical presentation is non specific, like flu illness, cardiogenic shock or sudden cardiac arrest. We report the case of a eight years old girl with a fulminant Influenza A-associated myocarditis with a fatal evolution despite the use of an extracorporeal membrane oxygenation (ECMO). The aim of this observation is to remind that influenza in children, usually considered as a benign illness, can exceptionally be complicated by a fulminant myocarditis. Because the possibility to recover a full myocardial function, the persistence of severe heart failure despite the medical treatment should conduct rapidly to a mechanical circulatory assistance.

Published
2006

32. Recombinant human acid -glucosidase: Major clinical benefits in infantile-onset Pompe disease

Author

Kishnani, P. S., primary, Corzo, D., additional, Nicolino, M., additional, Byrne, B., additional, Mandel, H., additional, Hwu, W. L., additional, Leslie, N., additional, Levine, J., additional, Spencer, C., additional, McDonald, M., additional, Li, J., additional, Dumontier, J., additional, Halberthal, M., additional, Chien, Y. H., additional, Hopkin, R., additional, Vijayaraghavan, S., additional, Gruskin, D., additional, Bartholomew, D., additional, van der Ploeg, A., additional, Clancy, J. P., additional, Parini, R., additional, Morin, G., additional, Beck, M., additional, De la Gastine, G. S., additional, Jokic, M., additional, Thurberg, B., additional, Richards, S., additional, Bali, D., additional, Davison, M., additional, Worden, M. A., additional, Chen, Y. T., additional, and Wraith, J. E., additional

Published
2011
Full Text
View/download PDF

34. Recombinant human acid -glucosidase: Major clinical benefits in infantile-onset Pompe disease

Author

Kishnani, P. S., primary, Corzo, D., additional, Nicolino, M., additional, Byrne, B., additional, Mandel, H., additional, Hwu, W. L., additional, Leslie, N., additional, Levine, J., additional, Spencer, C., additional, McDonald, M., additional, Li, J., additional, Dumontier, J., additional, Halberthal, M., additional, Chien, Y. H., additional, Hopkin, R., additional, Vijayaraghavan, S., additional, Gruskin, D., additional, Bartholomew, D., additional, van der Ploeg, A., additional, Clancy, J. P., additional, Parini, R., additional, Morin, G., additional, Beck, M., additional, De la Gastine, G. S., additional, Jokic, M., additional, Thurberg, B., additional, Richards, S., additional, Bali, D., additional, Davison, M., additional, Worden, M. A., additional, Chen, Y. T., additional, and Wraith, J. E., additional

Published
2006
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results